Literature DB >> 18462068

Role of PKCepsilon in PGF2alpha-stimulated MMP-2 secretion from human ciliary muscle cells.

Shahid Husain1, Craig E Crosson.   

Abstract

Studies were designed to examine the roles of individual protein kinase C (PKC) isoforms in the prostaglandin F(2alpha) (PGF(2alpha))-induced matrix metalloproteinase-2 (MMP-2) secretion from human ciliary muscle cells. Studies utilized primary cultures of human ciliary muscle cells. Individual PKC isoforms were detected by Western blotting, using PKC-isoform-specific antibodies. To evaluate MMP-2 secretion, cells were serum-starved overnight, treated with PGF(2alpha) (1 micromol/L) for 4 h and the media analyzed for MMP-2 by Western blotting. To assess ERK1/2 activation, cells were serum-starved overnight, treated with PGF(2alpha) (1 micromol/L) for 5 min and cell lysates analyzed for ERK1/2 phosphorylation by Western blot analysis. To evaluate the roles of individual PKC isoforms, cells were pretreated with PKC inhibitors or siRNAs prior to the addition of PGF(2alpha). In cultured human ciliary muscle cells, the PKC isoforms exhibiting the highest level of expression were PKCalpha, epsilon, iota and lambda. The delta and eta isoforms exhibited moderate levels of expression and beta, gamma, and phi were not detected. The administration of PGF(2alpha) (1 micromol/L) primarily induced the translocation of PKCepsilon from cytosol to the membrane fraction, as well as increased MMP-2 secretion and ERK1/2 phosphorylation. The secretion of MMP-2 was inhibited by pretreatment with the broad-range PKC inhibitor, chelerythrine chloride; however, this response was not blocked by Go-6976, an inhibitor of conventional PKC isoforms. The PGF(2alpha)-induced secretion of MMP-2 was also blocked by pretreatment with the PKCepsilon-selective peptide translocation inhibitor, EAVSLKPT, or the transfection of siRNA-targeting PKCepsilon. The activation of ERK1/2 was inhibited by chelerythrine and the PKCepsilon translocation inhibitor. Human ciliary muscle cells express the alpha, epsilon, iota and lambda PKC isoforms. Stimulation of FP receptors in these cells activates PKCepsilon, resulting in ERK1/2 activation and an eventual increase in MMP-2 secretion. These data support the idea that the activation of FP receptors in vivo modulate uveoscleral outflow through the PKCepsilon-dependent secretion of MMPs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462068      PMCID: PMC2981373          DOI: 10.1089/jop.2008.0014

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  48 in total

1.  Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro.

Authors:  J D Lindsey; K Kashiwagi; F Kashiwagi; R N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-10       Impact factor: 4.799

2.  A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function.

Authors:  J A Johnson; M O Gray; C H Chen; D Mochly-Rosen
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

3.  Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells.

Authors:  J D Lindsey; K Kashiwagi; D Boyle; F Kashiwagi; G S Firestein; R N Weinreb
Journal:  Curr Eye Res       Date:  1996-08       Impact factor: 2.424

4.  Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2 alpha analogue.

Authors:  J Stjernschantz; G Selén; B Sjöquist; B Resul
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1995

5.  Molecular evolution of receptors for eicosanoids.

Authors:  H Toh; A Ichikawa; S Narumiya
Journal:  FEBS Lett       Date:  1995-03-13       Impact factor: 4.124

Review 6.  Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow.

Authors:  J D Lindsey; K Kashiwagi; F Kashiwagi; R N Weinreb
Journal:  Surv Ophthalmol       Date:  1997-02       Impact factor: 6.048

7.  Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells.

Authors:  R N Weinreb; K Kashiwagi; F Kashiwagi; S Tsukahara; J D Lindsey
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-12       Impact factor: 4.799

8.  Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression.

Authors:  J P Alexander; J R Samples; T S Acott
Journal:  Curr Eye Res       Date:  1998-03       Impact factor: 2.424

9.  Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes.

Authors:  J W Adams; D S Migita; M K Yu; R Young; M S Hellickson; F E Castro-Vargas; J D Domingo; P H Lee; J S Bui; S A Henderson
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

10.  Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

Authors:  A Alm; J Stjernschantz
Journal:  Ophthalmology       Date:  1995-12       Impact factor: 12.079

View more
  4 in total

Review 1.  A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.

Authors:  Nahla E El-Ashmawy; Rania M Khalil
Journal:  Tumour Biol       Date:  2013-12-12

2.  Endothelial dysfunction and oxidative stress in polycystic kidney disease.

Authors:  Jelena Klawitter; Berenice Y Reed-Gitomer; Kim McFann; Alexander Pennington; Jost Klawitter; Kaleab Z Abebe; Jacek Klepacki; Melissa A Cadnapaphornchai; Godela Brosnahan; Michel Chonchol; Uwe Christians; Robert W Schrier
Journal:  Am J Physiol Renal Physiol       Date:  2014-09-18

3.  The roles of prostaglandin F2 in regulating the expression of matrix metalloproteinase-12 via an insulin growth factor-2-dependent mechanism in sheared chondrocytes.

Authors:  Pei-Pei Guan; Wei-Yan Ding; Pu Wang
Journal:  Signal Transduct Target Ther       Date:  2018-11-23

4.  Heparin binding VEGF isoforms attenuate hyperoxic embryonic lung growth retardation via a FLK1-neuropilin-1-PKC dependent pathway.

Authors:  Americo E Esquibies; Anil Karihaloo; Susan E Quaggin; Alia Bazzy-Asaad; Lloyd G Cantley
Journal:  Respir Res       Date:  2014-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.